Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001237899-15-000022)

Filing Details

Accession Number:: 0001237899-15-000022
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-27 16:31:46
Reporting Period:: 2015-02-27

Filing Date:: 2015-02-27
Accepted Time:: 2015-02-27 16:31:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403178	S Douglas Mccorkle	777 Old Saw Mill River Road Tarrytown NY 10591	Vp Controller And Asst Treasur	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-02-27	3,000	$416.24	4,481	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,129	Indirect	By 401(k) Plan

Footnotes

Represents volume-weighted average price of sales of 3,000 shares of Company stock on February 27, 2015 at prices ranging from $416.00 to $416.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2015 at each separate price.